The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations

Journal of Endocrinology

Volumn 213, Issue 1, 2012, Pages 25-36

  Vargas, Félix ^a   Rodríguez Gómez, Isabel ^a   Vargas Tendero, Pablo ^a   Jimenez, Eugenio ^b   Montiel, Mercedes ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSIDAD DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; LIOTHYRONINE; NITRIC OXIDE; RENIN; THYROID HORMONE; THYROTROPIN; THYROXINE; TRANSFORMING GROWTH FACTOR BETA1;

ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; ENZYME ACTIVITY; HEART ATRIUM FIBRILLATION; HEART OUTPUT; HEART TUMOR; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTOLIC DYSFUNCTION; TACHYCARDIA; THYROID DISEASE; ANIMAL; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT;

ANIMALS; CARDIOVASCULAR DISEASES; KIDNEY DISEASES; RATS; RENIN-ANGIOTENSIN SYSTEM; THYROID DISEASES;

EID: 84860832380     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0349     Document Type: Review

References (136)

1. Alfrey AC. 1986 Thyroid and parathyroid hormones in experimental renal failure. In The Progressive Nature of Renal Disease, pp 37-44. Eds BMBrenner & JH Stein. New York: Churchill Livingstone.
2. Andrade J, Haro JM, Jódar E, Luna JD & Vargas F 1992 Effects of methimazole on low renal mass hypertension: changes on blood pressure and pressor responsiveness to vasoconstrictors. Pharmacology 44 315-323.
3. Ashizawa K, Imaizumi M, Usa T, Tominaga T, Sera N, Hida A, Ejima E, Neriishi K, Soda M, Ichimaru S et al. 2010 Metabolic cardiovascular disease risk factors and their clustering in subclinical hypothyroidism. Clinical Endocrinology 72 689-695.
4. Atlas SA, Sealey JE, Larag JH & Moon C 1977 Plasma renin and "prorenin" in essential hypertension during sodium depletion, beta-blockade and reduced arterial pressure. Lancet 2 785-789.
5. Bader M. 2002 Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models. Journal of Molecular and Cellular Cardiology 34 1455-1462.
6. Baker KM & Aceto JF 1990 Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. American Journal of Physiology 259 H610-H618.
7. Barreto-Chaves MLM, Carrillo-Sepú lveda MA, Carneiro-Ramos MS, Gomes DA & Diniz GP 2010 The crosstalk between thyroid hormones and the renin-angiotensin system. Vascular Pharmacology 52 166-170.
8. Barth JD, Jansen H, Kromhout D, Reiber JH, Birkenhager JC & Arntzenius AC 1987 Progression and regression of human coronary atherosclerosis: the role of lipoproteins, lipases and thyroid hormones in coronary lesion growth. Atherosclerosis 68 51-58.
9. Bedotto JB, Gay RG, Graham SD, Morkin E & Goldman S 1989 Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade. Journal of Pharmacology and Experimental Therapeutics 248 632-636.
10. Boelen A, Platvoet-ter Schiphorst MC, Bakker O & Wiersinga WM 1995 The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice. Journal of Endocrinology 146 475-483.
11. Booz GW 2004 Cardiac angiotensin AT2 receptor: what exactly does it do? Hypertension 43 1162-1163
12. Bouhnik J, Galen FX, Clauser E, Menard J & Corvol P 1981 The renin- angiotensin system in thyroidectomized rats. Endocrinology 108 647-650.
13. Bradley SE, Stephan F, Coelho JB & Reville P 1974 The thyroid and the kidney. Kidney International 6 346-365.
14. Brent GA, Williams GR, Harney JW, Forman BM, Samuels HH, Moore DD & Larsen PR 1991 Effects of varying the position of thyroid hormone response elements within the rat growth hormone promoter: implications for positive and negative regulation by 3,5,30-triiodothyronine. Molecular Endocrinology 5 542-548.
15. Cai Y, Ren Y & Shi J 2011 Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data. Hypertension Research 34 1098-1105.
16. Carlin K & Carlin S 1993 Possible etiology for euthyroid sick syndrome. Medical Hypotheses 40 38-43.
17. Carneiro-Ramos MS, Silva VB, Santos RA & Barreto-Chaves ML 2006 Tissue-specific modulation of angiotensin-converting enzyme (ACE) in hyperthyroidism. Peptides 11 2942-2949.
18. Carneiro-RamosMS, Diniz GP, Almeida J, Vieira RL, Pinheiro SV, SantosRA & Barreto-Chaves ML 2007 Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism. Journal of Physiology 583 213-223.
19. Carneiro-Ramos MS, Diniz GP, Nadu AP, Almeida J, Vieira RL, Santos RA & Barreto-Chaves ML 2010 Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Research in Cardiology 105 325-335.
20. Casellas D, Bouriquet N & Herizi A 1997 Bosentan prevents preglomerular alterations during angiotensin II hypertension. Hypertension 30 1613-1620.
21. Chan JSD, Ming M, Nie ZR, Silkstrom R, Lachance S & Carrie're S 1992 Hormonal regulation of expression of the angiotensinogen gene in cultured opossum kidney proximal tubular cells. Journal of the American Society of Nephrology 2 1516-1522.
22. Chen K, Carey LC, Valego NK, Liu JL & Rose JC 2005 Thyroid hormone modulates renin and Ang II receptor expression in fetal sheep. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 289 R1006-R1014.
23. Churchill PC, Churchill MC & McDonald FD 1983 Evidence that beta 1-adrenoceptor activation mediates isoproterenol-stimulated renin secretion in the rat. Endocrinology 113 687-692.
24. Clauser E, Bouhnik J, Coezy E, Corvol P & Menard J 1983 Synthesis and release of immunoreactive angiotensiogen by rat liver slices. Endocrinology 112 1188-1193.
25. Conger JD, Falk SA & Gillum DM 1989 The protective mechanism of thyroidectomy in a rat model of chronic renal failure. American Journal of Kidney Diseases 13 217-225.
26. Cruz A, Rodríguez-Gómez I, Pérez-Abud R, Vargas Má, Wangensteen R, Quesada A, Osuna A & Moreno JM 2011 Effects of clofibrate on salt loading-induced hypertension in rats. Journal of Biomedicine & Biotechnology 2011 469481.
27. Dasarathy Y, Stevens J, Lanzillo JJ & Fanburg BL 1990 Elevation of angiotensin converting enzyme in bovine endothelial cells quantitated by an ELISA. Life Sciences 47 883-889.
28. Davis PJ, Davis FB & Cody V 2005 Membrane receptors mediating thyroid hormone action. Trends in Endocrinology and Metabolism 16 429-435.
29. Diniz GP, Carneiro-Ramos MS & Barreto-Chaves ML 2007 Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy. Pflügers Archiv 454 75-81.
30. Diniz GP, Carneiro-Ramos MS & Barreto-Chaves ML 2009 Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the AKT/GSK-3b/mTOR signaling pathway. Basic Research in Cardiology 104 653-667.
31. Donangelo I & Braunstein GD 2011 Update on subclinical hyperthyroidism. American Family Physician 83 933-938.
32. Dostal DE, Rothblum KN, Conrad KM, Cooper GR & Baker KM 1992 Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. American Journal of Physiology 263 C851-C863.
33. Duggal J, Singh S, Barsano CP & Arora R 2007 Cardiovascular risk with subclinical hyperthyroidism and hypothyroidism: pathophysiology and management. Journal of the Cardiometabolic Syndrome 2 198-206.
34. Dunn FG, Oigman W, Ventura HO, Messerli FH, Kobrin I & Frohlich ED 1984 Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. American Journal of Cardiology 53 105-108.
35. Dzau VJ & Herrmann HC 1982 Hormonal control of angiotensinogen production. Life Sciences 30 577-584.
36. Economidou F, Douka E, Tzanela M, Nanas S & Kotanidou A 2011 Thyroid function during critical illness. Hormones 10 117-124.
37. Emdin M, Passino C, Prontera C, Iervasi A, Ripoli A, Masini S, Zucchelli GC & Clerico A 2004 Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure. Clinical Chemistry and Laboratory Medicine 42 627-636.
38. Eppenberger-Eberhardt M, Aigner S, Donath MY, Kurer V, Walther P, Zuppinger C, Schaub MC & Eppenberger HM 1997 IGF-I and bFGF differentially influence atrial natriuretic factor and alpha-smooth muscle actin expression in cultured atrial compared to ventricular adult rat cardiomyocytes. Journal of Molecular and Cellular Cardiology 29 2027-2039.
39. Fischer P & Hilfiker-Kleiner D 2007 Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Research in Cardiology 102 279-297.
40. Folkow B 1990 Structural factor in primary and secondary hypertension. Hypertension 16 89-101.
41. Fontana M, Passino C, Poletti R, Zyw L, Prontera C, Scarlattini M, Clerico A, Emdin M & Iervasi G 2012 Low triiodothyronine and exercise capacity in heart failure. International Journal of Cardiology 154 153-157.
42. Fukuyama K, Ichiki T, Takeda K, Tokunou T, Iino N, Masuda S, Ishibashi M, Egashira K, Shimokawa H, Hirano K et al. 2003 Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension 41 598-603.
43. Furchgott RF & Vanhoutte PM 1989 Endothelium-derived relaxing and contracting factors. FASEB Journal 3 2007-2018.
44. Fyhrquist F & Saijonmaa O 2008 Renin-angiotensin system revisited. Journal of Internal Medicine 264 224-236.
45. Ganong WF 1982 Thyroid hormones and renin secretion. Life Sciences 30 577-584.
46. García del Río C, Moreno MR, Osuna A, Luna JD, García-Estan{ogonek} J & Vargas F 1997 Role of the renin-angiotensin system in the development of thyroxine-induced hypertension. European Journal of Endocrinology 136 656-660.
47. García-Estan{ogonek} J, Atucha N, Quesada T & Vargas F 1995 Involvement of the renin-angiotensin in the reduced pressure-natriuresis response of hyperthyroid rats. American Journal of Physiology 268 E897-E901.
48. Gilbert MT, Sun J, Yan Y, Oddoux C, Lazarus A, Tansey WP, Lavin TN & Catanzaro DF 1994 Renin gene promoter activity in GC is regulated by cAMP and thyroid hormone through Pit-1-dependent mechanisms. Journal of Biological Chemistry 269 28049-28054.
49. Gill GN, Ill CR & Simonian MH 1977 Angiotensin stimulation of bovine adrenocortical cell growth. PNAS 74 5569-5573.
50. Gottardis M, Koller J, Benzer A, Wieser C, Hackl JM, Koenigsrainer A, Herold M& Fridrich L 1992 Atrial natriuretic peptide (ANP), aldosterone, angiotensin II and renin in the 'low T3 syndrome' in organ donors. Infusionstherapie und Transfusionsmedizin 19 181-182. 185-186.
51. Guyton AC 1980 Arterial Pressure and Hypertension, p 564. Philadelphia: Saunders.
52. Haro JM, Sabio JM & Vargas F 1992 Renal and cardiac beta-adrenoceptors in thyroxine treated rats. Journal of Endocrinological Investigation 15 605-608.
53. Hauger-Klevene JH & Levin GM 1976 Kinetics of renin system in hyper- and hypothyroidism. Medicina 36 219-222.
54. Hauger-Klevene JH, De Vito E & Fasciolo JC 1977 The effect of thyroid hormone and renin production and release by rat kidney slices. Acta Physiologica Latino Americana 27 37-43.
55. Hekmat R, Javadi Z, Layghian Javan M, Sanadgol H, Gholami F, Mohebbi M, Zeraati AA, Ahmadnia H, Tabarraiei H, Baradaran M et al. 2010 Thyroid hormone changes in early kidney transplantation and its correlation with delayed graft function. Urology Journal 7 30-34.
56. Hermus RM, Sweep CG, Van der Meer MJ, Ross HA, Smals AG, Benraad TJ & Kloppenborg PW 1992 Continuous infusion of interleukin-1 beta induces a nonthyroidal illness syndrome in the rat. Endocrinology 131 2139-2146.
57. Hong-Brown LQ & Deschepper CF 1992 Effects of thyroid hormones on angiotensinogen gene expression in rat liver, brain and cultured cells. Endocrinology 130 1231-1237.
58. Hu LW, Benvenuti LA, Liberti EA, Carneiro-Ramos MS & Barreto-Chaves ML 2003 Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 285 R1473-R1480.
59. Ichihara A, Kobori H, Miyashita Y, Hayashi M & Saruta T 1998 Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells. American Journal of Physiology 274 E224-E231.
60. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney FA & Inagami T 2001 Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 104 346-351.
61. Ichiki T 2010 Thyroid hormone and atherosclerosis. Vascular Pharmacology 52 151-156.
62. Iervasi G, Pingitore A, Landi A, Raciti M, Ripoli A, Scarlattini M, L'Abbate A & Donato L 2003 Low-T3 syndrome a strong prognostic predictor of death in patients with heart disease. Circulation 107 708-713.
63. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ & Gruetter CA 1981 Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside, and nitric oxide: evidence for the involvement of nitrosothiols as active intermediates. Journal of Pharmacology and Experimental Therapeutics 218 739-749.
64. Jiménez E, Montiel M, Narváez JA & Morell M 1982 Effects of hyper and hypothyroidism on the basal levels of angiotensin I and kinetic parameters of renin angiotensin system in male rats. Revista Espan{ogonek}ola de Fisiología 38 149-154.
65. Jiménez E, Montiel M, Narváez JA & Morell M 1984 Renin-angiotensin system in hypothyroid rats: effects of potassium iodide and triiodo-Lthyronine. Acta Endocrinologica 105 505-510.
66. Jiménez E, Ruiz M & Montiel M 1990 Neonatal development of the angiotensin converting enzyme: effect of hypothyroidism. In Endocrine and Biochemical Development of the Fetus and Neonate, Ed. JM Cuezva. New York: Plenum.
67. Katz AM 2003 Pathophysiology of heart failure: identifying targets for pharmacotherapy. Medical Clinics of North America 87 303-316.
68. Kenessey A & Ojamaa K 2006 Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. Journal of Biological Chemistry 281 20666-20672.
69. Klein I 1988 Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol. Endocrinology 123 203-210.
70. Klein I 1990 Thyroid hormone and the cardiovascular system. American Journal of Medicine 88 631-637.
71. Klein I 2003 Thyroid hormone and cardiac contractility. American Journal of Cardiology 91 1331-1332.
72. Klein I & Ojamaa K 1995 Thyroid hormone and blood pressure regulation. In Hypertension: Pathophysiology, Diagnosis and Management, Eds JH Laragh & BN Brenner. New York: Raven Press Ltd.
73. Klein I & Ojamaa K 2001 Thyroid hormone and the cardiovascular system. New England Journal of Medicine 344 501-509.
74. Kobori H, Ichihara A, Suzuki H, Takenaka T, Miyashita Y, Hayashi M & Saruta T 1997a Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. American Journal of Physiology 273 H593-H599.
75. Kobori H, Ichihara A, Suzuki H, Miyashita Y, Hayashi M & Saruta T 1997b Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system. American Journal of Physiology 272 E227-E232.
76. Kobori H, Ichihara A, Miyashita Y, Hayashi M & Saruta T 1998 Mechanism of hyperthyroidism-induced renal hypertrophy in rats. Journal of Endocrinology 159 9-14.
77. Kobori H, Ichihara A, Miyashita Y, Hayashi M & Saruta T 1999 Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. Journal of Endocrinology 160 43-47.
78. Kobori H, Hayashi M & Saruta T 2001 Thyroid hormone stimulates renin gene expression through the thyroid hormone response element. Hypertension 37 99-104.
79. Koehn MA, Schindler WJ & Stanton HC 1967 Thyroid state and vascular reactivity in rats. Proceedings of the Society for Experimental Biology and Medicine 126 861-864.
80. Kozdag G, Ural D, Vural A, Agacdiken A, Kahraman G, Sahin T, Ural E & Komsuoglu B 2005 Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy. European Journal of Heart Failure 7 113-118.
81. Kumar R, Singh VP & Baker KM 2007 The intracellular renin-angiotensin system: a new paradigm. Trends in Endocrinology and Metabolism 18 208-214.
82. Kumar R, Singh VP & Baker KM 2008 The intracellular renin-angiotensin system: implications in cardiovascular remodeling. Current Opinion in Nephrology and Hypertension 17 168-173.
83. Kurtz A 2011 Renin release: sites, mechanisms and control. Annual Review of Physiology 73 377-399.
84. Kuzman JA, Vogelsang KA, Thomas TA & Gerdes AM 2005 L-thyroxine activates Akt signaling in the heart. Journal of Molecular and Cellular Cardiology 39 251-258.
85. Larsen PR, Davis TF & Hay ID 1998 The thyroid gland. In Williams Textbook of Endocrinology, Eds JD Wilson, DWFoster, HK Kronenberg & PR Larsen. London: WB Saunders & Company.
86. Lev-Ran A 1994 Thyroid hormones and prevention of atherosclerotic heart disease: an old-new hypothesis. Perspectives in Biology and Medicine 37 486-494.
87. Lim VS, Henriquez C, Seo H, Refetoff S &Martino E 1980 Thyroid function in a uremic rat model. Evidence suggesting tissue hypothyroidism. Journal of Clinical Investigation 66 946-954.
88. Lonn E, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley W, Teo K et al. 2001 Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103 919-925.
89. Marchant C, Brown L & Sernia C 1993 Renin-angiotensin system in thyroid dysfunction in rats. Journal of Cardiovascular Pharmacology 22 449-455.
90. McLeod JD & Piper PJ 1992 Effects of KC channel-modulating drugs on the vasoconstrictor responses of leukotrienes C4, D4 and angiotensin II in the guinea-pig isolated perfused heart. British Journal of Pharmacology 105 739-743.
91. Mebis L & Van den Berghe G 2011 Thyroid axis function and dysfunction in critical illness. Best Practice & Research. Clinical Endocrinology & Metabolism 25 745-757.
92. Michel B, Grima M, Coquard C, Welsch C, Barthelmebs M & Imbs JL 1994 Effects of triiodothyronine and dexamethasone on plasma and tissue angiotensin converting enzyme in the rat. Fundamental & Clinical Pharmacology 8 366-372.
93. Mifune M, Sasamura H, Shimizu-Hirota R, Miyazaki H & Saruta T 2000 Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells. Hypertension 36 845-850.
94. Mikhail GS, Alshammari SM, Alenezi MY, Mansour M & Khalil NA 2008 Increased atherogenic low-density lipoprotein cholesterol in untreated subclinical hypothyroidism. Endocrine Practice 14 570-575.
95. Millat LJ, Abdel-Rahman EM & Siragy HM 1999 Angiotensin II and nitric oxide: a question of balance. Regulatory Peptides 81 1-10.
96. Montiel M, Ruiz M, Jiménez E & Morell M 1987 Angiotensin converting enzyme in hyper- and hypothyroid rats. Hormone and Metabolic Research 19 90-92.
97. Moreno JM, Wangensteen R, Sainz J, Rodriguez-Gomez I, Chamorro V, Osuna A & Vargas F 2003 Role of endothelium-derived relaxing factors in the renal response to vasoactive agents in hypothyroid rats. American Journal of Physiology. Endocrinology and Metabolism 285 E182-E189.
98. Moreno JM, Rodríguez-Gómez I, Wangensteen R, Osuna A, Bueno P & Vargas F 2005 Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats. American Journal of Physiology. Endocrinology and Metabolism 289 E776-E783.
99. Morgan HE & Baker KM 1991 Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation 83 13-25.
100. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J & Rodondi N 2008 Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Annals of Internal Medicine 148 832-845.
101. Perez-Abud R, Rodríguez-Gómez I, VillarejoAB, Moreno JM, Wangensteen R, Tassi M, O'Valle F, Osuna A & Vargas F 2011 Salt sensitivity in experimental thyroid disorders in rats. American Journal of Physiology. Endocrinology and Metabolism 301 E281-E287.
102. Peti-Peterdi J 2010 High glucose and renin release: the role of succinate and GPR91. Kidney International 78 1214-1217.
103. Phillips MI, Speakman EA & Kimura B 1993 Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regulatory Peptides 43 1-20.
104. Pingitore A, Landi P, Taddei MC, Ripoli A, L'Abbate A & Iervasi G 2005 Triiodothyronine levels for risk stratification of patients with chronic heart failure. American Journal of Medicine 118 132-136.
105. Pingitore A, Galli E, Barison A, Iervasi A, Scarlattini M, Nucci D, L'Abbate A, Mariotti R & Iervasi G 2008 Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 93 1351-1358.
106. Prieto-Carrasqueo MC, Botros FT, Kobori H & Navar LG 2009 Collecting duct renin: a major player in angiotensin II-dependent hypertension. Journal of the American Society of Hypertension 3 96-104.
107. Razvi S, Weaver JU, Vanderpump MP & Pearce SH 2010 The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. Journal of Clinical Endocrinology and Metabolism 95 1734-1740.
108. Reiners C, Gramer-Kurz E, Pickert E & Schweisfurth H 1988 Changes of serum angiotensin-I-converting enzyme in patients with thyroid disorders. Clinical Physiology and Biochemistry 6 44-49.
109. Rodríguez-Gómez I, Sainz J, Wangensteen R, Moreno JM, Duarte J, Osuna A & Vargas F 2003 Increased pressor ensitivity to chronic nitric oxide deficiency in hyperthyroid rats. Hypertension 42 220-225.
110. Romaldini JH, Sgarbi JA & Farah CS 2004 Subclinical thyroid disease: subclinical hypothyroidism and hyperthyroidism. Arquivos Brasileiros de Endocrinologia e Metabologia 48 147-158.
111. Ruiz M, Montiel M, Jiménez E & Morell M. 1987 Effect of thyroid hormones on angiotensinogen production in rat in vivo and in vitro. Journal of Endocrinology 115 311-315.
112. Sabineau JP & Marthan R 1993 Effect of cromakalim on KCl-, noradrenaline- and angiotensin II-induced contractions in the rat pulmonary artery. Pulmonary Pharmacology 6 41-48.
113. Sabio JM, Rodríguez-Maresca M, Luna JD, García del Rio C & Vargas F. 1994 Vascular reactivity to vasoconstrictors in aorta and renal vasculature from hyperthyroid and hypothyroid rats. Pharmacology 49 257-264.
114. 1 receptor subtype. Circulation Research 73 413-423.
115. Sahún M, Villabona C, Rosel P, Navarro MA, Ramón JM, Gómez JM & Soler J 2001 Water metabolism disturbances at different stages of primary thyroid failure. Journal of Endocrinology 168 435-445.
116. Santos RA & Ferreira AJ 2007 Angiotensin-(1-7) and the renin-angiotensin system. Current Opinion in Nephrology and Hypertension 16 122-128.
117. Segarra AB, Ramírez M, Banegas I, Hermoso F, Vargas F, Vives F, Alba F, de Gasparo M & Prieto I 2006 Influence of thyroid disorders on kidney angiotensinase activity. Hormone and Metabolic Research 38 48-52.
118. Sernia C, Marchant C, Brown L & Hoey A 1993 Cardiac angiotensin receptors in experimental hyperthyroidism in dogs. Cardiovascular Research 27 423-428.
119. Stephan F, Reville P, de Laharpe F & Köll-Back MH 1982 Impairment of renal compensatory hypertrophy by hypothyroidism in the rat. Life Sciences 30 623-631.
120. Strawn WB, Chappell MC, Dean RH, Kivlighn S & Ferrario CM 2000 Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 101 1586-1593.
121. Tanwani LK, Lohano V, Broadstone VL & Mokshagundam SP 2002 Minimal change nephropathy and Graves' disease: report of a case and review of the literature. Endocrine Practice 8 40-43.
122. Tognini S, Marchini F, Dardano A, Polini A, Ferdeghini M, Castiglioni M & Monzani F 2010 Non-thyroidal illness syndrome and short-term survival in a hospitalised older population. Age and Ageing 39 46-50.
123. UrataH, Kinoshita A, Misono KS, Bumpus FM&Husain A 1990 Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. Journal of Biological Chemistry 265 22348-22357.
124. Van Lente F & Daher R 1992 Plasma selenium concentrations in patients with euthyroid sick syndrome. Clinical Chemistry 38 1885-1888.
125. Vargas F, García del Rio C, Luna JD, Haro JM & Osorio C 1988 Studies on thyroid activity in deoxycorticosterone-salt and Goldblatt two-kidney, one-clip hypertensive rats. Acta Endocrinologica 118 22-30.
126. Vargas F, Baz MJ, Andrade J, Luna JD & Haro JM 1991 Thyroid state and pressor responsiveness to vasoconstrictors in conscious rats. Medical Science Research 19 239-241.
127. Vargas F, Castillo MA & Haro JM 1992 Methimazole treatment reduces cardiac hypertrophy and mortality without a concomitant reduction in blood pressure in established Goldblatt two-kidney one clip hypertension. Experientia 48 755-758.
128. Vargas F, Atucha N, Sabio JM, Quesada T & García-Estan{ogonek} J 1994 Pressure diuresis-natriuresis response in hyperthyroid and hypothyroid rats. Clinical Science 87 323-328.
129. Vargas F, Fernández-Rívas A, García-Estan{ogonek} J & Garcia del Rio C 1995 Endothelium-dependent and endothelium-independent vasodilation in hyperthyroid and hypothyroid rats. Pharmacology 51 308-314.
130. Vargas F, Moreno JM, Rodríguez-Gómez I, Wangensteen R, Osuna A, Alvarez-Guerra M & García-Estan{ogonek} J 2006 Vascular and renal function in experimental thyroid disorders. European Journal of Endocrinology 154 197-212.
131. Vargas SL, Toma I, Kang JJ, Meer EJ & Peti-Peterdi J 2009 Activation of the succinate receptor GPR91 in macula densa cells causes renin release. Journal of the American Society of Nephrology 20 1002-1011.
132. Wada H, Zile MR, Ivester CT, Cooper G IV & McDermott PJ 1996 Comparative effects of contraction and angiotensin II on growth of adult feline cardiocytes in primary culture. American Journal of Physiology 271 H29-H37.
133. Warner MH & Beckett GJ 2010 Mechanisms behind the non-thyroidal illness syndrome: an update. Journal of Endocrinology 205 1-13.
134. Weetman AP, Tomlinson K, Amos N, Lazarus JH, Hall R & McGregor AM 1985 Proteinuria in autoimmune thyroid disease. Acta Endocrinologica 109 341-347.
135. Williams GR, Franklyn JA, Neuberger JM & Sheppard MC 1989 Thyroid hormone receptor expression in the sick euthyroid syndrome. Lancet 2 1477-1478.
136. Zoccali C, Tripepi G, Cutrupi S, Pizzini P & Mallamaci F 2005 Low triiodothyronine: a new facet of inflammation in end-stage renal disease. Journal of the American Society of Nephrology 16 2789-2795.